Clinical outcomes of desensitization in intermediate-risk kidney transplant recipients: A dual-center study
Transplant Immunology · 2026-08 · 97 · 102408
DOI: 10.1016/j.trim.2026.102408 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Transplant Immunology, 2026-08. Verfasst von Muhammad A Bukhari und 6 weiteren Autor:innen. Beteiligte Einrichtung: Multi-organ Transplant Center, King Abdullah Medical City, Makkah, Saudi Arabia. Electronic address: bukhary5354@hotmail.com. Hauptthemen laut MEDLINE: Desensitization, Immunologic, Graft Rejection, Immunoglobulins, Intravenous, Kidney Failure, Chronic. Die Arbeit nennt 28 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND Kidney transplantation has been the optimal treatment of end-stage renal disease (ESRD). Preformed donor-specific antibodies (DSA) lead to elevated morbidity of antibody-mediated rejection (ABMR). Desensitization is a targeted strategy to decrease the probability of adverse consequences of the post-transplantation outcomes. The purpose of this study was to compare the results and risks of standard kidney transplantation versus a moderately elevated DSA level (DSA
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Multi-organ Transplant Center, King Abdullah Medical City, Makkah, Saudi Arabia. Electronic address: bukhary5354@hotmail.com.
- Multi-organ Transplant Center, King Abdullah Medical City, Makkah, Saudi Arabia.
- Department of Nephrology and Transplantation, Al-Hada Armed Forces Hospital, Taif, Saudi Arabia.
- Department of Medicine, College of Medicine, Umm Al-Qura University (UQU), Makkah, Saudi Arabia.
Zitieren
APA
Bukhari, M. A., Habibullah, Z. N., Alazwari, M., Alotaibi, M. E., Alotaibi, M., Almarwani, A., & Hussein, M. A. (2026). Clinical outcomes of desensitization in intermediate-risk kidney transplant recipients: A dual-center study. Transplant Immunology, 97, 102408. https://doi.org/10.1016/j.trim.2026.102408
Vancouver
Bukhari MA, Habibullah ZN, Alazwari M, Alotaibi ME, Alotaibi M, Almarwani A, et al. Clinical outcomes of desensitization in intermediate-risk kidney transplant recipients: A dual-center study. Transplant Immunology. 2026;97:102408. doi:10.1016/j.trim.2026.102408
BibTeX
@article{Bukhari2026,
author = {Bukhari, Muhammad A and Habibullah, Zainab N and Alazwari, Monther and Alotaibi, Manal E and Alotaibi, Mutlaq and Almarwani, Abdulhakim and Hussein, Mohamed A},
title = {Clinical outcomes of desensitization in intermediate-risk kidney transplant recipients: A dual-center study},
journal = {Transplant Immunology},
year = {2026},
volume = {97},
pages = {102408},
doi = {10.1016/j.trim.2026.102408}
}
EUVIMED